Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder

British Journal of Cancer

Volumn 75, Issue 10, 1997, Pages 1489-1496

  Tachibana, M ^a   Miyakawa, A ^a   Uchida, A ^a   Murai, M ^a   Eguchi, K ^a   Nakamura, K ^a   Kubo, A ^a   Hata, J I ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Bladder cancer; Cell growth promotion; Granulocyte colony stimulating factor receptor; In situ reverse transcriptase polymerase chain reaction

Indexed keywords

COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BLADDER CANCER; CANCER GROWTH; DISSOCIATION CONSTANT; GRANULOCYTE; HUMAN; HUMAN CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA;

EID: 0030910566     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.254     Document Type: Article

References (39)

1. Akaza H, Fukushima H, Koiso K and Aso Y (1992) Enhancement of chemotherapeutic effects by recombinant human granulocyte colony-stimulating factor on implanted mouse bladder cancer cells (MBT-2). Cancer 69: 997-1002
2. Aso Y and Akaza H (1992) Urological rhG-CSF study group: effect of recombinant human granulocyte colony-stimulating factor in patients receiving chemotherapy for urological cancer. J Urol 147: 1060-1064
3. Avalos BR, Gasson JC, Hedvat C, Quan SG, Baldwin GC, Weisbart RH, Williams RE, Golde DW and DiPersio JF (1990) Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood 75: 851-857
4. Avalos BR (1996) Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88: 761-777
5. Bailly J-D, Pourquier P, Jaffrezou J-P, Duchayne E, Cassar G, Bordier C and Laurent G (1995) Effect of 5637-conditioned medium and recombinant cytokines on P-glycoprotein expression in a human GM-CSF-dependent leukemic myeloid cell line. Leukemia 9: 1718-1725
6. Basu A, Raghunath M, Bishayee S and Das M (1989) Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor from that binds to EGF: role for interreceptor interaction in kinase regulation. Mol Cell Biol 9: 671-677
7. Begley CG, Metcalf D and Nicola NA (1987) Primary human myeloid leukemia cells: comparative responsiveness to proliferate stimulation by GM-CSF or G-CSF and membrane expression of CSF receptors. Leukemia 1: 1-8
8. Block T, Treiber U, Geffken B, Vogel M, Hanauske A-R, Schmid F, Hartung R and Busch R (1993) Inhibitory effects on in vitro cell growth of human urothelial tumor cell lines under the combined administration of hematopoietic growth factors and clinically relevant antineoplastic agents. Urol Res 21: 217-221
9. Bussolino F, Wang JM, Defilippi P, Turrini F, Sanavio F, Edgell CJ, Aglietta M, Arese P and Matovani A (1989) Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337: 471-473
10. Chomozynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Chem 162: 156-159
11. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tubbara I, Kris M, Grous J, Picozzi V, Rausch G, Smith R, Gradishar W, Yahanda A, Vincent M, Stewart M and Glaspy J (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 315: 164-170
12. Demetri GD and Griffin JD (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78: 2791-2808
13. Fremand J-P, Levy Y, Gerota J, Benbunan M, Casset JM, Castaigne S, Seligmann M and Brouet J-C (1989) Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft. Blood 73: 20-23
14. Gabrilove J (1991) Hematopoietic growth factors in the supportive care and treatment of patients with hematologic malignancies. In Neoplastic Diseases of the Blood. Wiernick PH, Canellos GP, Kyle RA and Schiffer CA. (eds), pp. 949-965. Churchill Livingstone: New York, NY
15. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MAS, Clarkson B, Oettgen HF, Alton K, Welte K and Souza L (1988a) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the uroepithelium. N Eng J Med 318: 1414-1422
16. Gabrilove JL, Jakubowski A, Fain K, Grous J, Scher H, Sternberg C, Yagoda A, Clarkson B, Bonilla MA, Oettgen HF, Alton K, Boone T, Altrock B, Welte K and Souza L (1988b) Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 82: 1454-1461
17. Juttner CA, To LB, Ho JQK, Bardy PG, Dyson PG, Haylock DN and Kimber RJ (1988) Early lympho-hematopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. Trans Proc 20: 40-43
18. Kessinger A, Armitage JO, Landmark JD and Weisenburger DD (1986) Reconstitution of human hematopoietic function with autologous, cryopreserved circulating stem cells. Exp Hematol 14: 192-196
19. Kessinger A, Armitage JO, Smith DM, Landmark JD, Bierman PJ and Weisenburger DD (1989) High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 74: 1260-1266
20. Lasky LC, Bostrom B, Smith J, Moss, TJ and Ramsay NKC (1989) Clinical collection and use of peripheral blood stem cells in pediatric patients. Transplantation 47: 613-616
21. Masaoka T, Takaku F, Kato S, Moriyamam Y, Kodera Y, Kanamura A, Shimosato A, Shibata H and Nakamura H (1989) Recombinant human granulocyte colony-stimulating factor in allogenic bone marrow transplantation. Exp Hematol 17: 1047-1050
22. Mignatti P, Robbins E and Rifkin DB (1986) Tumor invasion through the human amniotic membrane: requirement for a protease cascade. Cell 47: 487-498
23. Miyanaga N, Akaza H, Shimazui T, Ohtani M and Koiso K (1994) The effect of dose intensity on M-VAC therapy for advanced urothelial cancer. Cancer Chemother Pharmacol 35: (suppl.) S5-S8
24. Mizutani Y, Okada Y, Terachi T, Kakei Y and Yoshida O (1995) Serum granulocyte colony-stimulating factor levels in patients with urinary bladder tumour and various urological malignancies. Br J Urol 76: 580-586
25. Morstyn G, Campbell L, Souza LM, Alton NK, Keech J, Green M, Sheridan W, Metcalf D and Fox R (1988) Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1: 667-672
26. 125I-labeled granulocyte colony-stimulating factor to normal murine hematopoietic cells. J Cell Physiol 124: 313-321
27. Nuovo GJ, Lidonocci K, MacConnell P and Lane B (1993) Intracellular localization of polymerase chain reaction-amplified hepatitis C cDNA. Am J Surg Pathol 17: 683-690
28. Nuovo GJ, MacConnell PB, Simsir A, Valea F and French DL (1995) Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 55: 267-275
29. Ohigashi T (1990) Granulocyte-colony stimulating factor enhances the cytotoxic effects of methotrexate to bladder cancer cells in vitro. Keio J Med 39: 254-260
30. Ohigashi T, Tachibana M, Tazaki H and Nakamura K (1992) Bladder cancer cells express functional receptors for granulocyte-colony stimulating factor. J Urol 147: 283-286
31. Ohno R, Tomonaga M, Kobayashi T, Kanamaru A, Shirakawa S, Masaoka T, Omine M, Oh H, Nomura T, Sakai Y, Hirano M, Yokomaru S, Nakayama S, Yoshida Y, Miura AB, Morishita Y, Dohy H, Niho Y, Hamajima N and Takaku F (1990) Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med 323: 871-877
32. Park LS, Waldron PE, Friend D, Sassenfeld HM, Price V, Anderson D, Cosman D, Andrews RG, Bernstein ID and Urdal DL (1989) Interleukin-3, GM-CSF and G-CSF receptor expression on cell lines and primary leukemia cells. Blood 74: 56-65
33. Piao Y-F and Okabe T (1990) Receptor binding of human granulocyte colony-stimulating factor to the blast cells of myeloid leukemia. Cancer Res 50: 1671-1674
34. Scher HI (1992) Systemic chemotherapy in regionally advanced bladder cancer: theoretical considerations and results. Urol Clin North Am 19: 747-759
35. Tachibana M (1982) Studies on cellular adhesiveness in live different culture cell lines derived from carcinoma of the urinary bladder. Keio J Med 31: 127-148
36. Tachibana M, Miyakawa A, Tazaki H, Nakamura K, Kubo A, Hata J, Nishi T and Amano Y (1995) Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res 55: 3438-3443
37. Taylor KM, Jagannath S, Spitzer F, Spinolo JA, Tucker SL, Fogel B, Cabanillas FF, Hagemeiste FB and Souza LM (1989) Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery alter high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J Clin Oncol 7: 1791-1799
38. Uzumaki H, Okabe T, Sasaki N, Hagiwara K, Takaku F, Tobita M, Yasukawa K, Ito S and Umezawa Y (1989) Identification and characterization of receptors for granulocyte colony-stimulating factor on human placenta and trophoblastic cells. Proc Natl Acad Sci USA 86: 9323-9326
39. Veldhuis JD, Johnson ML, Faunt LM, Mercado M and Baumann G (1993) Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles free and bound GH and on the apparent half-life of GH. J Clin Invest 91: 629-641